Aclidinium
- Generic Name
- Aclidinium
- Brand Names
- Bretaris Genuair, Duaklir, Duaklir Genuair, Eklira Genuair, Tudorza, Tudorza Genuair, Brimica Genuair
- Drug Type
- Small Molecule
- Chemical Formula
- C26H30NO4S2
- CAS Number
- 727649-81-2
- Unique Ingredient Identifier
- K17VY42F6C
Overview
Aclidinium is an anticholinergic for the long-term management of chronic obstructive pulmonary disease (COPD). It has a much higher propensity to bind to muscarinic receptors than nicotinic receptors. FDA approved on July 24, 2012.
Background
Aclidinium is an anticholinergic for the long-term management of chronic obstructive pulmonary disease (COPD). It has a much higher propensity to bind to muscarinic receptors than nicotinic receptors. FDA approved on July 24, 2012.
Indication
用于治疗慢性支气管炎或肺气肿引起的急性支气管痉挛。
Associated Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/02/28 | Phase 4 | Recruiting | |||
2017/11/06 | N/A | Completed | |||
2017/09/21 | N/A | Completed | |||
2017/09/08 | Phase 2 | Completed | |||
2017/09/08 | Phase 1 | Completed | |||
2017/09/07 | Phase 4 | UNKNOWN | |||
2017/06/09 | Phase 4 | Withdrawn | |||
2017/04/07 | Phase 3 | Completed | McGill University Health Centre/Research Institute of the McGill University Health Centre | ||
2017/01/16 | Phase 3 | Completed | |||
2016/11/23 | Phase 4 | Completed |
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|---|---|---|---|---|
RESPIRATORY (INHALATION) | 400 ug in 1 1 | 2022/08/01 | 70515-002 | ||
RESPIRATORY (INHALATION) | 400 ug in 1 1 | 2022/01/25 | 0310-0900 | ||
RESPIRATORY (INHALATION) | 400 ug in 1 1 | 2021/02/23 | 0310-0800 | ||
RESPIRATORY (INHALATION) | 400 ug in 1 1 | 2022/08/01 | 70515-001 |
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|---|---|---|---|---|---|---|---|
EMEA/H/C/002211 | the netherlands | N/A | Authorised | 2012/07/20 | N/A | 21 | ||
EMEA/H/C/002706 | the netherlands | N/A | Authorised | 2012/07/20 | N/A | 20 | ||
EMEA/H/C/003745 | the netherlands | N/A | Authorised | 2014/11/19 | 2014/09/25 | 16 | ||
EMEA/H/C/003969 | the netherlands | N/A | Authorised | 2014/11/19 | N/A | 16 |
HSA Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
|---|
No HSA products found
No HSA products found for this drug
NMPA Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|---|---|---|---|---|---|---|---|---|
国药准字HJ20240081 | 吸入粉雾剂 | N/A | 每个吸入器60吸，每吸含阿地溴铵400μg，递送剂量为阿地溴铵375µg | Chemical Drug | Approved | 2024/08/05 | Import |
PPB Approved Products
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
|---|
No PPB products found
No PPB products found for this drug
TGA Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|---|---|---|---|---|
224899 | A Menarini Australia Pty Ltd | Active | 2015/05/01 | aclidinium bromide | |
206071 | A Menarini Australia Pty Ltd | Active | 2014/03/25 | aclidinium bromide |
© Copyright 2025. All Rights Reserved by MedPath